Precision medicine is personalized medical care based on the genetic profiles of patients. At Ayass BioScience, we use high-throughput Next Generation Sequencing technologies to sequence cancer patients’ solid tumor DNA. Targeted sequencing of tumor DNA across our panel of 26 cancer driving genes can detect tumor biopsy somatic mutations that may be targets for personalized therapeutics.
Next Generation Sequencing of Solid Tumor DNA
By Larisa|2020-05-17T17:37:54-05:00November 8th, 2016|Breast Cancer, Genetic Testing, Next Generation Sequencing, Solid Tumor|0 Comments
Leave A Comment